Paxil Linked To Heart Defects In Babies, Philly Jury Told

Law360, Philadelphia (March 24, 2016, 7:29 PM EDT) -- After being barred from presenting opinions in federal multidistrict litigation over the antidepressant Zoloft, a Philadelphia jury heard testimony on Thursday from an expert witness about what she said were clear links between GlaxoSmithKline PLC’s antidepressant drug Paxil and cardiac birth defects.

University of Montreal researcher Anick Berard, whose testimony was rejected from the Zoloft MDL after a federal judge ruled in June 2014 that she’d strayed from established epidemiological methods, told the jury that more than a dozen studies on Paxil showed a consistent association...
To view the full article, register now.